TLCR Insider Trading Activity and SEC Form 4 Filings
TLCR insider trading summary
No open-market insider purchases or sales of Talecris Biotherapeutics Holdings Corp. (TLCR) have been reported on SEC Form 4 in the past 12 months.
Latest TLCR insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Feb 1, 2011 | Mary J Kuhn | Executive VP, Operations | Sell | $1.3M (54,697 @ $24.36) |
| Feb 1, 2011 | Stephen R Petteway Jr | Executive VP, R&D | Sell | $609K (25,000 @ $24.37) |
| Feb 1, 2011 | Joel E Abelson | Sr VP & GM, Int'l Bus. | Sell | $366K (15,000 @ $24.38) |
| Jan 3, 2011 | Stephen R Petteway Jr | Executive VP, R&D | Sell | $577K (25,000 @ $23.06) |
| Jan 3, 2011 | Joel E Abelson | Sr VP & GM, Int'l Bus. | Sell | $1.0M (45,000 @ $23.08) |
| Jan 3, 2011 | Mary J Kuhn | Executive VP, Operations | Sell | $1.3M (54,697 @ $23.08) |
| Dec 1, 2010 | Stephen R Petteway Jr | Executive VP, R&D | Sell | $538K (25,000 @ $21.50) |
| Dec 1, 2010 | James R Engle | Sr. VP, Information Technology | Sell | $589K (27,408 @ $21.50) |
| Nov 1, 2010 | Stephen R Petteway Jr | Executive VP, R&D | Sell | $609K (25,000 @ $24.37) |
| Nov 1, 2010 | James R Engle | Sr. VP, Information Technology | Sell | $308K (12,656 @ $24.37) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.